Bonus Issue of Shares: Thyrocare Technologies Ltd

Thyrocare Technologies Ltd has announced a significant bonus issue of equity shares, reinforcing its commitment to strengthening shareholder value and enhancing market liquidity. As per the latest exchange filing, the company will issue two (2) bonus equity shares of ₹10 face value for every one (1) existing equity share of ₹10 face value held.

This generous 2:1 bonus ratio substantially increases the number of shares held by investors while keeping the total investment value proportionately unchanged. The bonus issue reflects the company's strategic aim to reward long-term shareholders and encourage wider retail participation in its equity.

Key Details of the Bonus Issue

The company has officially stated that 10,61,07,794 bonus equity shares will be allotted on December 1, 2025, in line with the approved bonus ratio.

Example: Impact on Your Thyrocare Holdings

Here’s how this corporate action may affect your portfolio:

• If you hold 166 shares, you will receive 266 bonus shares, making your total holding 432 shares.

• If you hold 1,000 shares, you will receive 2,000 bonus shares, increasing your total holding to 3,000 shares.

Although the stock price will adjust downward to reflect the increased number of shares, your overall investment value remains the same—ensuring no dilution of wealth while enhancing liquidity.

What is a Bonus Issue?

A bonus issue is a corporate action in which additional shares are distributed to existing shareholders without any additional cost. This is done by converting the company’s accumulated reserves into share capital.

Bonus issues are often seen as a sign of:

• Strong financial health

• Confidence in future earnings

• A desire to reward shareholders

• Efforts to increase liquidity and accessibility

In the case of Thyrocare Technologies Ltd, the 2:1 bonus ratio significantly expands the shareholder base and is likely to improve market participation.

Conclusion

The bonus issue announced by Thyrocare Technologies Ltd underscores the company’s dedication to enhancing shareholder value and broadening investor engagement. With a substantial 2:1 ratio, the move is expected to strengthen liquidity, improve trading volumes, and support long-term investor confidence.

This initiative reflects management’s commitment to growth, transparency, and shareholder-centric decision-making.